文献速递心力衰竭与心肌病

射血分数保留、临界和降低的心力衰竭:5年结局

Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes.
PubMed 文献 · J Am Coll Cardiol · 2017-11-12

研究基于GWTG-HF登记链接Medicare数据,纳入2005-2009年254家医院因心衰住院的39,982例患者,按EF分为HFpEF(≥50%)、HFbEF(41%-49%)和HFrEF(≤40%)。风险调整后三组5年死亡率相似(HFrEF 75.3% vs HFpEF 75.7%;HFbEF 75.7% vs HFpEF 75.7%),复合死亡与再住院亦相似,但HFrEF和HFbEF的心血管及心衰再入院率高于HFpEF。

要点

  • 住院心衰患者整体5年死亡率约75%,中位生存仅2.1年。
  • 风险调整后HFpEF、HFbEF、HFrEF的5年死亡风险无显著差异。
  • HFrEF和HFbEF的心血管及心衰再入院率高于HFpEF。

核心结论

  • 因心衰住院的患者 across EF谱具有相似的较差5年生存,且心血管和心衰入院风险升高。

研究设计与样本

  • 研究链接GWTG-HF登记与Medicare数据,纳入2005-2009年254家医院因心衰住院的39,982例患者进行纵向随访。

主要发现

  • 18,299例(46%)为HFpEF,3,285例(8.2%)为HFbEF,18,398例(46%)为HFrEF,总体中位生存2.1年。
  • 风险调整后5年死亡率:HFrEF 75.3% vs HFpEF 75.7%,HR 0.99(95%CI 0.958-1.022);HFbEF 75.7% vs HFpEF 75.7%,HR 0.99(95%CI 0.947-1.046)。
  • 风险调整后死亡与再住院复合终点在各亚组间相似。
  • HFrEF和HFbEF的心血管及心衰再入院率高于HFpEF。
  • 与U.S.人群相比,所有年龄和EF组的心衰患者中位生存显著更低。

临床怎么用

  • 应同等重视不同EF心衰患者的长期管理,尤其关注再入院预防。
  • HFrEF和HFbEF患者需加强心血管及心衰再入院的监测与干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with heart failure (HF) have a poor prognosis and are categorized by ejection fraction (EF). OBJECTIVES: This study sought to characterize differences in outcomes in patients hospitalized with heart failure with preserved ejection fraction (HFpEF) (EF ≥50%), heart failure with borderline ejection fraction (HFbEF) (EF 41% to 49%), and heart failure with reduced ejection fraction (HFrEF) (EF ≤40%). METHODS: Data from GWTG-HF (Get With The Guidelines-Heart Failure) were linked to Medicare data for longitudinal follow-up. Multivariable models were constructed to examine 5-year outcomes and to compare survival to median survival of the U.S. RESULTS: A total of 39,982 patients from 254 hospitals who were admitted for HF between 2005 and 2009 were included: 18,299 (46%) had HFpEF, 3,285 (8.2%) had HFbEF, and 18,398 (46%) had HFrEF. Overall, median survival was 2.1 years. In risk-adjusted survival analysis, all 3 groups had similar 5-year mortality (HFrEF 75.3% vs. HFpEF 75.7%; hazard ratio: 0.99 [95% confidence interval: 0.958 to 1.022]; HFbEF 75.7% vs. HFpEF 75.7%; hazard ratio: 0.99 [95% confidence interval: 0.947 to 1.046]). In risk-adjusted analyses, the composite of mortality and rehospitalization was similar for all subgroups. Cardiovascular and HF readmission rates were higher in those with HFrEF and HFbEF compared with those with HFpEF. When compared with the U.S. population, HF patients across all age and EF groups had markedly lower median survival. CONCLUSIONS: Among patients hospitalized with HF, patients across the EF spectrum have a similarly poor 5-year survival with an elevated risk for cardiovascular and HF admission. These findings underscore the need to improve treatment of patients with HF.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Shah KS, Xu H, Matsouaka RA, et al. Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes. J Am Coll Cardiol. 2017. PMID: 29141781. doi:10.1016/j.jacc.2017.08.074

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。